Clinical Trials Directory

Trials / Completed

CompletedNCT01357512

Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer

Evaluation of Diagnostic Value of 3-T MRI in Suspected Prostate Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
University of Oulu · Academic / Other
Sex
Male
Age
40 Years – 72 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the usefulness of 3-T magnetic resonance imaging (MRI) in the evaluation of suspected prostate cancer. Men with suspected prostate cancer based on serum prostate-specific antigen antigen (PSA) value are included. Men are randomized to pre-biopsy MRI or no MRI groups in ratio 1:1. Standard transrectal ultrasound guided biopsies will be taken in addition to extra biopsies from lesions suspicious based on MRI evaluation. Hypothesis is that more prostate cancers will be found after MRI evaluation.

Conditions

Interventions

TypeNameDescription
DEVICEmagnetic resonance imaging, SiemensMagnetic resonance imaging (MRI) of prostate with Siemens 3-tesla device

Timeline

Start date
2011-04-01
Primary completion
2014-12-01
Completion
2017-09-01
First posted
2011-05-20
Last updated
2017-12-02
Results posted
2015-06-17

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01357512. Inclusion in this directory is not an endorsement.